A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

CompletedOBSERVATIONAL
Enrollment

141

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Infusion Reaction
Trial Locations (7)

29210

South Carolina Oncology Associates, PA, Columbia

30501

Northeast Georgia Medical Center, Gainesville

30901

Medical Oncology Associates of Augusta, Augusta

37023

Tennessee Oncology, PLLC, Nashville

40207

Baptist Hospital East, Louisville

63017

St. Louis Cancer Care, Chesterfield

72401

Northeast Arkansas Clinic, Jonesboro

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER